Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins

influenza A virus (IAV) influenza B virus (IBV) influenza C virus (ICV) influenza D virus (IDV) innate immunity interferon (IFN) non-structural protein 1 (NS1) signal transducer and activator of transcription 2 (STAT2)

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2019
Historique:
received: 20 09 2019
accepted: 26 11 2019
entrez: 11 1 2020
pubmed: 11 1 2020
medline: 11 1 2020
Statut: epublish

Résumé

Influenza viruses are important pathogens that affect multiple animal species, including humans. There are four types of influenza viruses: A, B, C, and D (IAV, IBV, ICV, and IDV, respectively). IAV and IBV are currently circulating in humans and are responsible of seasonal epidemics (IAV and IBV) and occasional pandemics (IAV). ICV is known to cause mild infections in humans and pigs, while the recently identified IDV primarily affect cattle and pigs. Influenza non-structural protein 1 (NS1) is a multifunctional protein encoded by the NS segment in all influenza types. The main function of NS1 is to counteract the host antiviral defense, including the production of interferon (IFN) and IFN-stimulated genes (ISGs), and therefore is considered an important viral pathogenic factor. Despite of homologous functions, the NS1 protein from the diverse influenza types share little amino acid sequence identity, suggesting possible differences in their mechanism(s) of action, interaction(s) with host factors, and contribution to viral replication and/or pathogenesis. In addition, although the NS1 protein of IAV, IBV and, to some extent ICV, have been previously studied, it is unclear if IDV NS1 has similar properties. Using an approach that allow us to express NS1 independently of the nuclear export protein from the viral NS segment, we have generated recombinant IAV expressing IAV, IBV, ICV, and IDV NS1 proteins. Although recombinant viruses expressing heterotypic (IBV, ICV, and IDV) NS1 proteins were able to replicate similarly in canine MDCK cells, their viral fitness was impaired in human A549 cells and they were highly attenuated

Identifiants

pubmed: 31921042
doi: 10.3389/fmicb.2019.02862
pmc: PMC6927920
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2862

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI141607
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI141889
Pays : United States

Informations de copyright

Copyright © 2019 Nogales, Aydillo, Ávila-Pérez, Escalera, Chiem, Cadagan, DeDiego, Li, García-Sastre and Martínez-Sobrido.

Références

J Infect Dis. 2018 Jun 20;218(2):176-178
pubmed: 29361111
Int J Mol Sci. 2016 Dec 22;18(1):
pubmed: 28025504
J Virol. 2015 Oct;89(20):10696-701
pubmed: 26246567
Mol Cell. 1998 Jun;1(7):991-1000
pubmed: 9651582
Virus Res. 1986 May;4(3):263-73
pubmed: 2943090
Cytokine Growth Factor Rev. 2016 Jun;29:71-81
pubmed: 27053489
J Virol. 2017 Oct 27;91(22):
pubmed: 28835506
J Virol. 2012 Oct;86(19):10293-301
pubmed: 22787224
J Virol. 2011 May;85(10):5228-31
pubmed: 21411538
J Gen Virol. 2003 Dec;84(Pt 12):3263-74
pubmed: 14645908
Sci Rep. 2017 Sep 15;7(1):11660
pubmed: 28916759
J Virol. 2006 Apr;80(8):3957-65
pubmed: 16571812
JAKSTAT. 2014 Jan 1;3(1):e27715
pubmed: 24778924
Sci Rep. 2018 Mar 12;8(1):4374
pubmed: 29531320
Cell Host Microbe. 2016 Jun 8;19(6):882-90
pubmed: 27212660
J Virol. 2017 Feb 14;91(5):
pubmed: 28003482
Viruses. 2018 Sep 13;10(9):
pubmed: 30217093
J Virol. 2018 Mar 14;92(7):
pubmed: 29321309
RNA. 1998 Jan;4(1):55-64
pubmed: 9436908
Virology. 2006 May 25;349(1):13-21
pubmed: 16466763
Science. 2000 May 12;288(5468):1051-3
pubmed: 10807575
J Vis Exp. 2017 Sep 7;(127):
pubmed: 28930978
J Gen Virol. 2008 Jan;89(Pt 1):1-47
pubmed: 18089727
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4309-14
pubmed: 10725408
Virol J. 2013 Jul 25;10:243
pubmed: 23886034
J Virol. 2007 Jan;81(2):514-24
pubmed: 17079289
Nat Rev Microbiol. 2019 Jan;17(2):67-81
pubmed: 30487536
PLoS Pathog. 2009 Jan;5(1):e1000252
pubmed: 19119420
Cell Microbiol. 2016 May;18(5):692-704
pubmed: 26518983
J Virol. 2007 Jul;81(13):7011-21
pubmed: 17442719
J Virol. 2010 Dec;84(24):12761-70
pubmed: 20926573
RNA. 1995 May;1(3):304-16
pubmed: 7489502
Genes Dev. 1994 Aug 1;8(15):1817-28
pubmed: 7958859
J Virol. 2019 Dec 12;94(1):null
pubmed: 31597767
J Virol. 1994 Apr;68(4):2425-32
pubmed: 7908060
Cell Microbiol. 2007 Jul;9(7):1641-6
pubmed: 17506818
Curr Top Microbiol Immunol. 2009;333:177-95
pubmed: 19768406
J Virol. 2018 Feb 12;92(5):
pubmed: 29237829
Nucleic Acids Res. 1999 Jun 1;27(11):2241-7
pubmed: 10325410
J Virol. 2015 Mar;89(6):3421-6
pubmed: 25552727
J Gen Virol. 1997 May;78 ( Pt 5):1059-63
pubmed: 9152423
Front Immunol. 2018 Sep 25;9:2151
pubmed: 30337919
Virology. 2008 Dec 5;382(1):107-14
pubmed: 18929379
Viruses. 2019 Feb 22;11(2):
pubmed: 30813325
J Virol. 2010 Jul;84(14):6909-22
pubmed: 20444891
J Gen Virol. 2009 Dec;90(Pt 12):2990-4
pubmed: 19726611
J Gen Virol. 2014 Dec;95(Pt 12):2594-611
pubmed: 25182164
Methods Mol Biol. 2017;1602:205-238
pubmed: 28508223
J Virol. 2009 Feb;83(4):1742-53
pubmed: 19073731
J Virol. 2010 Feb;84(4):1957-66
pubmed: 20007279
J Virol. 2014 Sep;88(18):10778-91
pubmed: 25008914
J Virol. 2014 Oct;88(20):12146-51
pubmed: 25078692
J Virol. 2010 Feb;84(4):1847-55
pubmed: 19939929
Virology. 1998 Dec 20;252(2):324-30
pubmed: 9878611
mBio. 2019 Mar 12;10(2):
pubmed: 30862743
J Gen Virol. 2008 Oct;89(Pt 10):2359-76
pubmed: 18796704
J Gen Virol. 2013 May;94(Pt 5):985-95
pubmed: 23343627
Viruses. 2018 Oct 15;10(10):
pubmed: 30326610
PLoS One. 2018 Sep 7;13(9):e0202787
pubmed: 30192781
PLoS One. 2016 Jan 25;11(1):e0147723
pubmed: 26809059
Science. 2012 Jun 22;336(6088):1534-41
pubmed: 22723413
Virol J. 2011 Feb 02;8:48
pubmed: 21288362
N Engl J Med. 2018 Jan 4;378(1):7-9
pubmed: 29185857
J Virol. 2011 Jul;85(14):7048-58
pubmed: 21593152
J Gen Virol. 2010 Sep;91(Pt 9):2331-40
pubmed: 20519456
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
Virus Res. 2016 Feb 2;213:69-81
pubmed: 26590325
Cell Rep. 2013 Jan 31;3(1):23-9
pubmed: 23333274
J Virol. 2016 Aug 26;90(18):8251-65
pubmed: 27384661
BMC Res Notes. 2014 Jan 09;7:22
pubmed: 24405943
J Clin Med. 2019 Feb 05;8(2):null
pubmed: 30764577
J Virol. 2015 Mar;89(6):2990-4
pubmed: 25540375
J Gen Virol. 1992 Jan;73 ( Pt 1):17-25
pubmed: 1530962
Viruses. 2018 Dec 12;10(12):
pubmed: 30545063
Virology. 2015 Feb;476:206-216
pubmed: 25553516
J Virol. 2014 Sep;88(18):10525-40
pubmed: 24965472
J Virol. 2010 Nov;84(21):11219-26
pubmed: 20739532
J Gen Virol. 2017 Sep;98(9):2267-2273
pubmed: 28869005
J Virol. 2006 Dec;80(23):11667-77
pubmed: 16987984
Virology. 2008 Aug 15;378(1):1-5
pubmed: 18585749
Virulence. 2017 Nov 17;8(8):1580-1591
pubmed: 28812422
J Virol. 2018 Sep 12;92(19):
pubmed: 30021892
Am J Respir Cell Mol Biol. 2007 Mar;36(3):263-9
pubmed: 17053203
J Virol. 2008 Nov;82(21):10580-90
pubmed: 18768976
J Mol Evol. 2008 Jun;66(6):655-63
pubmed: 18504518
EMBO J. 2001 Feb 1;20(3):362-71
pubmed: 11157743
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Curr Top Microbiol Immunol. 2014;385:359-75
pubmed: 24990620
J Gen Virol. 1997 Oct;78 ( Pt 10):2447-51
pubmed: 9349463
J Virol. 2006 Sep;80(18):9192-9
pubmed: 16940530
J Virol. 2018 Feb 26;92(6):
pubmed: 29321324
J Virol. 2003 Jan;77(2):1501-11
pubmed: 12502864
Infect Disord Drug Targets. 2007 Dec;7(4):336-43
pubmed: 18220965
Proc Natl Acad Sci U S A. 1980 Apr;77(4):1857-61
pubmed: 6246509
J Virol. 2017 Aug 10;91(17):
pubmed: 28637750
Virology. 2017 Jan;500:1-10
pubmed: 27750071
Curr Opin Virol. 2015 Oct;14:71-8
pubmed: 26364134
J Virol. 2018 Feb 12;92(5):
pubmed: 29237841
Viruses. 2019 Feb 19;11(2):
pubmed: 30791465
Science. 2013 Feb 1;339(6119):520-1
pubmed: 23345603
Int Immunol. 2013 Dec;25(12):663-9
pubmed: 24158954
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12084-8
pubmed: 21730147
Cell Rep. 2018 Dec 4;25(10):2784-2796.e3
pubmed: 30517866
J Virol. 2006 Jul;80(13):6295-304
pubmed: 16775317
J Virol. 2016 Oct 14;90(21):9693-9711
pubmed: 27535054
Virology. 2012 Oct 10;432(1):194-203
pubmed: 22770925
Curr Top Microbiol Immunol. 2015;386:301-21
pubmed: 25007847
Nature. 2015 Nov 5;527(7576):114-7
pubmed: 26503046
Science. 2009 Jul 24;325(5939):481-3
pubmed: 19574348
Vaccine. 2017 Oct 9;35(42):5708-5713
pubmed: 28890196
Nat Rev Immunol. 2014 May;14(5):315-28
pubmed: 24762827
Cell Microbiol. 2007 Apr;9(4):930-8
pubmed: 17140406
J Virol. 2016 Jun 24;90(14):6291-6302
pubmed: 27122587
Front Microbiol. 2018 Oct 24;9:2546
pubmed: 30405591
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11531-6
pubmed: 20534532

Auteurs

Aitor Nogales (A)

Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, NY, United States.
Centro de Investigación en Sanidad Animal, Madrid, Spain.

Teresa Aydillo (T)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Gines Ávila-Pérez (G)

Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, NY, United States.

Alba Escalera (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Kevin Chiem (K)

Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, NY, United States.

Richard Cadagan (R)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Marta L DeDiego (ML)

Department of Molecular and Cell Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

Feng Li (F)

Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD, United States.

Adolfo García-Sastre (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Luis Martínez-Sobrido (L)

Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, NY, United States.

Classifications MeSH